News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
128 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (29145)
Month
January (2935)
February (2968)
March (2707)
April (2905)
May (3623)
June (2409)
July (2086)
August (2588)
September (2381)
October (3062)
November (1481)
Day
1 (150)
2 (125)
3 (95)
5 (29)
6 (105)
7 (106)
8 (131)
9 (140)
10 (84)
13 (72)
14 (99)
15 (146)
16 (136)
17 (106)
19 (47)
20 (160)
21 (173)
22 (150)
23 (143)
24 (76)
26 (1)
27 (133)
28 (187)
29 (138)
30 (128)
31 (202)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
31
Press Releases
Telitacicept Demonstrates Sustained Efficacy and Favorable Safety Profile in 48-Week China Phase 3 Open-Label Extension Generalized Myasthenia Gravis Data
October 30, 2025
·
6 min read
Press Releases
Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials
October 30, 2025
·
10 min read
Press Releases
Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
October 30, 2025
·
6 min read
Press Releases
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States
October 30, 2025
·
6 min read
Press Releases
Medical Milestone: Children’s Hospital of Philadelphia Performs Its First Artificial Heart Surgery on Infant with Complex Congenital Heart Disease
October 30, 2025
·
4 min read
Press Releases
Vistagen Appoints Paul Edick to its Board of Directors
October 30, 2025
·
5 min read
Press Releases
Rarity PBC Raises $4.6 Million Seed Financing to Advance Gene Therapy for ADA-SCID
October 30, 2025
·
4 min read
Press Releases
Curve Biosciences Raises $40 Million to Bring Whole-Body Intelligence to Chronic Disease Monitoring
October 30, 2025
·
3 min read
Press Releases
FDA Accepts BioMarin’s PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria
October 30, 2025
·
14 min read
Press Releases
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research
October 30, 2025
·
5 min read
Previous
5 of 13
Next